# Universal Electronics Inc: financial statements, quarterly

UEIC · Nasdaq · CIK 101984 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ueic.md) · [Financials](/companies/ueic/financials.md) · [Filings](/companies/ueic/filings.md) · [Insiders](/companies/ueic/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ueic/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [107](/filings/0000101984-24-000172.md) | [97.6 d](/filings/0000101984-26-000039.md) | [91.9](/filings/0000101984-25-000105.md) | [90.5](/filings/0000101984-25-000193.md) | [102](/filings/0000101984-25-000226.md) | [110 d](/filings/0000101984-26-000039.md) | [92.3](/filings/0000101984-26-000058.md) | [97.7](/filings/0000101984-26-000110.md) | [90.6](/filings/0000101984-25-000226.md) | [87.7 d](/filings/0000101984-26-000039.md) | [79.0](/filings/0000101984-26-000058.md) | [73.2](/filings/0000101984-26-000110.md) |
| Cost of revenue | $m | [86.7](/filings/0000101984-24-000172.md) | [69.8 d](/filings/0000101984-26-000039.md) | [65.9](/filings/0000101984-25-000105.md) | [64.5](/filings/0000101984-25-000193.md) | [71.3](/filings/0000101984-25-000226.md) | [79.1 d](/filings/0000101984-26-000039.md) | [66.2](/filings/0000101984-26-000058.md) | [68.5](/filings/0000101984-26-000110.md) | [65.4](/filings/0000101984-25-000226.md) | [61.7 d](/filings/0000101984-26-000039.md) | [58.4](/filings/0000101984-26-000058.md) | [47.3](/filings/0000101984-26-000110.md) |
| Gross profit | $m | [20.4](/filings/0000101984-24-000172.md) | [27.8 d](/filings/0000101984-26-000039.md) | [26.0](/filings/0000101984-25-000105.md) | [26.0](/filings/0000101984-25-000193.md) | [30.7](/filings/0000101984-25-000226.md) | [31.3 d](/filings/0000101984-26-000039.md) | [26.1](/filings/0000101984-26-000058.md) | [29.2](/filings/0000101984-26-000110.md) | [25.1](/filings/0000101984-25-000226.md) | [26.1 d](/filings/0000101984-26-000039.md) | [20.6](/filings/0000101984-26-000058.md) | [25.9](/filings/0000101984-26-000110.md) |
| Research and development | $m | [7.7](/filings/0000101984-24-000172.md) | [6.8 d](/filings/0000101984-26-000039.md) | [7.8](/filings/0000101984-25-000105.md) | [7.5](/filings/0000101984-25-000193.md) | [7.3](/filings/0000101984-25-000226.md) | [7.0 d](/filings/0000101984-26-000039.md) | [7.2](/filings/0000101984-26-000058.md) | [7.0](/filings/0000101984-26-000110.md) | [6.7](/filings/0000101984-25-000226.md) | [5.4 d](/filings/0000101984-26-000039.md) | [5.5](/filings/0000101984-26-000058.md) | [4.3](/filings/0000101984-26-000110.md) |
| Selling, general and administrative | $m | [23.1](/filings/0000101984-24-000172.md) | [23.3 d](/filings/0000101984-26-000039.md) | [24.0](/filings/0000101984-25-000105.md) | [21.3](/filings/0000101984-25-000193.md) | [22.9](/filings/0000101984-25-000226.md) | [23.6 d](/filings/0000101984-26-000039.md) | [22.6](/filings/0000101984-26-000058.md) | [21.2](/filings/0000101984-26-000110.md) | [22.1](/filings/0000101984-25-000226.md) | [19.4 d](/filings/0000101984-26-000039.md) | [19.0](/filings/0000101984-26-000058.md) | [16.8](/filings/0000101984-26-000110.md) |
| Operating income | $m | [(14.0)](/filings/0000101984-24-000172.md) | [(2.6) d](/filings/0000101984-26-000039.md) | [(6.9)](/filings/0000101984-25-000105.md) | [(4.5)](/filings/0000101984-25-000193.md) | [0.4](/filings/0000101984-25-000226.md) | [(4.4) d](/filings/0000101984-26-000039.md) | [(3.8)](/filings/0000101984-26-000058.md) | [1.0](/filings/0000101984-26-000110.md) | [(4.5)](/filings/0000101984-25-000226.md) | [0.9 d](/filings/0000101984-26-000039.md) | [(3.9)](/filings/0000101984-26-000058.md) | [4.8](/filings/0000101984-26-000110.md) |
| Income tax | $m | [3.3](/filings/0000101984-24-000172.md) | [2.6 d](/filings/0000101984-26-000039.md) | [0.7](/filings/0000101984-25-000105.md) | [2.8](/filings/0000101984-25-000193.md) | [2.5](/filings/0000101984-25-000226.md) | [(0.6) d](/filings/0000101984-26-000039.md) | [2.2](/filings/0000101984-26-000058.md) | [1.8](/filings/0000101984-26-000110.md) | [2.6](/filings/0000101984-25-000226.md) | [0.0 d](/filings/0000101984-26-000039.md) | [3.6](/filings/0000101984-26-000058.md) | [1.1](/filings/0000101984-26-000110.md) |
| Net income | $m | [(19.4)](/filings/0000101984-24-000172.md) | [(7.1) d](/filings/0000101984-26-000039.md) | [(8.6)](/filings/0000101984-25-000226.md) | [(8.2)](/filings/0000101984-25-000226.md) | [(2.7)](/filings/0000101984-25-000226.md) | [(4.5) d](/filings/0000101984-26-000039.md) | [(6.3)](/filings/0000101984-26-000110.md) | [(2.9)](/filings/0000101984-26-000110.md) | [(8.3)](/filings/0000101984-25-000226.md) | [(1.1) d](/filings/0000101984-26-000039.md) | [(7.3)](/filings/0000101984-26-000110.md) | [1.6](/filings/0000101984-26-000110.md) |
| Diluted EPS | $ per share | [(1.50)](/filings/0000101984-24-000172.md) | not reported | [(0.67)](/filings/0000101984-25-000105.md) | [(0.63)](/filings/0000101984-25-000193.md) | [(0.20)](/filings/0000101984-25-000226.md) | not reported | [(0.48)](/filings/0000101984-26-000058.md) | [(0.22)](/filings/0000101984-26-000110.md) | [(0.62)](/filings/0000101984-25-000226.md) | not reported | [(0.58)](/filings/0000101984-26-000058.md) | [0.12](/filings/0000101984-26-000110.md) |
| Basic EPS | $ per share | [(1.50)](/filings/0000101984-24-000172.md) | not reported | [(0.67)](/filings/0000101984-25-000105.md) | [(0.63)](/filings/0000101984-25-000193.md) | [(0.20)](/filings/0000101984-25-000226.md) | not reported | [(0.48)](/filings/0000101984-26-000058.md) | [(0.22)](/filings/0000101984-26-000110.md) | [(0.62)](/filings/0000101984-25-000226.md) | not reported | [(0.58)](/filings/0000101984-26-000058.md) | [0.13](/filings/0000101984-26-000110.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [60.1](/filings/0000101984-23-000058.md) | [42.8](/filings/0000101984-25-000038.md) | [26.9](/filings/0000101984-24-000068.md) | [23.1](/filings/0000101984-24-000132.md) | [26.3](/filings/0000101984-24-000172.md) | [26.8](/filings/0000101984-26-000039.md) | [27.4](/filings/0000101984-25-000105.md) | [34.3](/filings/0000101984-25-000193.md) | [31.5](/filings/0000101984-25-000226.md) | [32.3](/filings/0000101984-26-000110.md) | [29.8](/filings/0000101984-26-000058.md) | [32.4](/filings/0000101984-26-000110.md) |
| Current assets | $m | [282](/filings/0000101984-23-000058.md) | [259](/filings/0000101984-25-000038.md) | [230](/filings/0000101984-24-000068.md) | [226](/filings/0000101984-24-000132.md) | [237](/filings/0000101984-24-000172.md) | [242](/filings/0000101984-26-000039.md) | [232](/filings/0000101984-25-000105.md) | [227](/filings/0000101984-25-000193.md) | [209](/filings/0000101984-25-000226.md) | [205](/filings/0000101984-26-000110.md) | [189](/filings/0000101984-26-000058.md) | [204](/filings/0000101984-26-000110.md) |
| Total assets | $m | [378](/filings/0000101984-23-000058.md) | [356](/filings/0000101984-25-000038.md) | [323](/filings/0000101984-24-000068.md) | [314](/filings/0000101984-24-000132.md) | [321](/filings/0000101984-24-000172.md) | [323](/filings/0000101984-26-000039.md) | [311](/filings/0000101984-25-000105.md) | [304](/filings/0000101984-25-000193.md) | [281](/filings/0000101984-25-000226.md) | [274](/filings/0000101984-26-000110.md) | [255](/filings/0000101984-26-000058.md) | [267](/filings/0000101984-26-000110.md) |
| Current liabilities | $m | [183](/filings/0000101984-23-000058.md) | [161](/filings/0000101984-25-000038.md) | [139](/filings/0000101984-24-000068.md) | [141](/filings/0000101984-24-000132.md) | [148](/filings/0000101984-24-000172.md) | [158](/filings/0000101984-26-000039.md) | [149](/filings/0000101984-25-000105.md) | [140](/filings/0000101984-25-000193.md) | [125](/filings/0000101984-25-000226.md) | [119](/filings/0000101984-26-000110.md) | [106](/filings/0000101984-26-000058.md) | [115](/filings/0000101984-26-000110.md) |
| Total liabilities | $m | [197](/filings/0000101984-23-000058.md) | [177](/filings/0000101984-25-000038.md) | [153](/filings/0000101984-24-000068.md) | [154](/filings/0000101984-24-000132.md) | [160](/filings/0000101984-24-000172.md) | [170](/filings/0000101984-26-000039.md) | [161](/filings/0000101984-25-000105.md) | [151](/filings/0000101984-25-000193.md) | [135](/filings/0000101984-25-000226.md) | [128](/filings/0000101984-26-000110.md) | [116](/filings/0000101984-26-000058.md) | [124](/filings/0000101984-26-000110.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [182](/filings/0000101984-23-000058.md) | [179](/filings/0000101984-26-000039.md) | [170](/filings/0000101984-25-000226.md) | [160](/filings/0000101984-25-000226.md) | [161](/filings/0000101984-25-000226.md) | [153](/filings/0000101984-26-000110.md) | [150](/filings/0000101984-26-000110.md) | [153](/filings/0000101984-26-000110.md) | [146](/filings/0000101984-25-000226.md) | [146](/filings/0000101984-26-000110.md) | [139](/filings/0000101984-26-000110.md) | [143](/filings/0000101984-26-000110.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [6.8 d](/filings/0000101984-24-000172.md) | [5.1 d](/filings/0000101984-26-000039.md) | [(2.8)](/filings/0000101984-25-000105.md) | [5.5 d](/filings/0000101984-25-000193.md) | [5.7 d](/filings/0000101984-25-000226.md) | [6.5 d](/filings/0000101984-26-000039.md) | [9.0](/filings/0000101984-26-000058.md) | [8.7 d](/filings/0000101984-26-000110.md) | [10.1 d](/filings/0000101984-25-000226.md) | [(4.2) d](/filings/0000101984-26-000039.md) | [(0.8)](/filings/0000101984-26-000058.md) | [6.3 d](/filings/0000101984-26-000110.md) |
| Capital expenditure | $m | [1.0 d](/filings/0000101984-24-000172.md) | [1.3 d](/filings/0000101984-26-000039.md) | [1.3](/filings/0000101984-25-000105.md) | [1.3 d](/filings/0000101984-25-000193.md) | [0.8 d](/filings/0000101984-25-000226.md) | [1.0 d](/filings/0000101984-26-000039.md) | [1.0](/filings/0000101984-26-000058.md) | [1.2 d](/filings/0000101984-26-000110.md) | [0.9 d](/filings/0000101984-25-000226.md) | [0.7 d](/filings/0000101984-26-000039.md) | [0.8](/filings/0000101984-26-000058.md) | [0.8 d](/filings/0000101984-26-000110.md) |
| Share repurchases | $m | [0.0 d](/filings/0000101984-24-000172.md) | [0.9 d](/filings/0000101984-26-000039.md) | [1.2](/filings/0000101984-25-000105.md) | [0.6 d](/filings/0000101984-25-000193.md) | [0.1 d](/filings/0000101984-25-000226.md) | [0.1 d](/filings/0000101984-26-000039.md) | [0.4](/filings/0000101984-26-000058.md) | [0.4 d](/filings/0000101984-26-000110.md) | [0.0 d](/filings/0000101984-25-000226.md) | [2.3 d](/filings/0000101984-26-000039.md) | [0.0](/filings/0000101984-26-000058.md) | [0.0 d](/filings/0000101984-26-000110.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [12.7](/filings/0000101984-23-000058.md) | [12.7](/filings/0000101984-24-000068.md) | [12.9](/filings/0000101984-24-000132.md) | [12.9](/filings/0000101984-24-000172.md) | [12.9](/filings/0000101984-25-000105.md) | [12.9](/filings/0000101984-25-000193.md) | [13.0](/filings/0000101984-25-000226.md) | [13.1](/filings/0000101984-26-000058.md) | [13.2](/filings/0000101984-26-000110.md) | [13.3](/filings/0000101984-25-000226.md) | [12.6](/filings/0000101984-26-000058.md) | [13.4](/filings/0000101984-26-000110.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 12,885,062 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0000101984-26-000110.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.